Table 1. Cytotoxicity of Anticancer Drugs (IC50) Obtained by CCK-8 and RTCA Assays.
IC50 (μg/mL) |
||||
---|---|---|---|---|
HeLa |
A549 |
|||
drug | CCK-8a | RTCA | CCK-8 | RTCA |
doxorubicin | 0.368 ± 0.059 | 0.364 | ||
CCM | 27.0 ± 2.40 | 10.6 | 24.0 | 9.61 |
CPT-11 | 35.5 ± 6.51 | 17.2 | ||
taxol | 1.08 ± 0.016 | 1.07 | ||
oxaliplatin | 16.5 ± 0.334 | 17.1 |
CCK-8 assay was conducted in triplicate to ensure the accuracy. CPT-11: irinotecan hydrochloride.